Search Results for "Trileptal"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Trileptal. Results 1 to 10 of 13 total matches.
See also: oxcarbazepine

Two New Drugs for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Apr 17, 2000  (Issue 1076)
FOR ONLINE USERS TWO NEW DRUGS FOR EPILEPSY Oxcarbazepine (Trileptal − Novartis), which is chemically ...
Oxcarbazepine, which is chemically similar to carbamazepine, and levetiracetam, a pyrrolidine acetamide chemically unrelated to other antiepileptic drugs, are the sixth and seventh drugs approved by the US Food and Drug Administration in the last five years for oral use in partial seizures.
Med Lett Drugs Ther. 2000 Apr 17;42(1076):33-5 |  Show IntroductionHide Introduction

Eslicarbazepine Acetate (Aptiom) for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • May 26, 2014  (Issue 1443)
) Oxcarbazepine – 150, 300, 600 mg 1200-2400 mg generic tabs; 300 mg/5 mL divided bid 114.60 Trileptal (Novartis ...
Eslicarbazepine acetate (Aptiom – Sunovion) has been approved by the FDA for adjunctive treatment of partial-onset seizures in adults. New drugs for epilepsy are often approved by the FDA initially only as adjunctive treatment for partial seizures. Eslicarbazepine acetate is a prodrug of eslicarbazepine, which is the S-isomer of the active metabolite of oxcarbazepine. Oxcarbazepine itself is similar to carbamazepine. Both oxcarbazepine and carbamazepine are available generically.
Med Lett Drugs Ther. 2014 May 26;56(1443):42-3 |  Show IntroductionHide Introduction

Zonisamide (Zonegran) For Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Oct 02, 2000  (Issue 1089)
137.66 Oxcarbazepine − Trileptal (Novartis) bid 1200 to 2400 mg 30 mg/kg 3 179.49 Phenytoin − average ...
Zonisamide (Zonegran - Elan Pharma), a sulfonamide chemically unrelated to other antiepileptic drugs, has been approved by the FDA for adjunctive use in adults with partial seizures. Zonisamide has been available in Japan for more than 10 years.
Med Lett Drugs Ther. 2000 Oct 2;42(1089):94-5 |  Show IntroductionHide Introduction

Extended-Release Carbamazepine (Equetro) for Bipolar Disorder

   
The Medical Letter on Drugs and Therapeutics • Mar 28, 2005  (Issue 1205)
Sedation, hyponatremia Trileptal divided bid 184.50 Risperidone – Risperdal Acute mania/mixed 1-6 mg once ...
An extended-release formulation of carbamazepine, available since 1997 for treatment of epilepsy, has now been approved under a new name, Equetro, for acute mania and mixed episodes of bipolar disorder. Although the drug was effective in some patients for up to 6 months, it has not been approved for maintenance treatment. Carbamazepine has not been shown to be more effective than lithium or valproate, and it can cause serious adverse effects.
Med Lett Drugs Ther. 2005 Mar 28;47(1205):27-8 |  Show IntroductionHide Introduction

Drug Interactions with Simvastatin

   
The Medical Letter on Drugs and Therapeutics • Oct 20, 2008  (Issue 1297)
) Fosphenytoin (Cerebyx) Nafcillin Nevirapine (Viramune) Oxcarbazepine (Trileptal) Phenytoin (Dilantin ...
A recent letter to the editor of the Annals of Internal Medicine documented a single case of myopathy apparently due to an interaction between simvastatin (Zocor, and others) and green tea. Since it became available generically, simvastatin has surpassed atorvastatin (Lipitor) as the best selling statin. As such, it is probably the most common cause of statin-induced myopathy, which is often a result of drug interactions.
Med Lett Drugs Ther. 2008 Oct 20;50(1297):83-4 |  Show IntroductionHide Introduction

Ezogabine (Potiga) for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Aug 20, 2012  (Issue 1397)
, 300, 600 mg tabs 1200-2400 mg in 2 112.80 Trileptal (Novartis) 150, 300, 600 mg tabs; divided doses ...
The FDA has approved ezogabine (ee-ZOE-ga-been; Potiga – GSK/Valeant) for oral adjunctive treatment of partial-onset seizures in adults. Ezogabine is available in Europe as retigabine (Trobalt).
Med Lett Drugs Ther. 2012 Aug 20;54(1397):65-7 |  Show IntroductionHide Introduction

Pregabalin (Lyrica) for Neuropathic Pain and Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Sep 12, 2005  (Issue 1217)
), lamotrigine (Lamictal) or oxcarbazepine (Trileptal) are the drugs of choice for partial, including ...
Pregabalin (Lyrica - Pfizer), a structural analog of gamma-aminobutyric acid (GABA) similar to gabapentin (Neurontin - Pfizer, and others), which recently became available generically, has been approved by the FDA for treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and diabetic peripheral neuropathy (DPN), and for adjunctive treatment of partial onset seizures in adults with epilepsy.
Med Lett Drugs Ther. 2005 Sep 12;47(1217):75-6 |  Show IntroductionHide Introduction

Lacosamide for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Jun 29, 2009  (Issue 1315)
Oxcarbazepine – generic 150, 300, 600 mg tabs 1200-2400 mg 247.20 Trileptal (Novartis) 150, 300, 600 mg tabs ...
The FDA has approved lacosamide (Vimpat - UCB Pharma) for oral or intravenous (IV) use as add-on therapy in adults with partial-onset seizures.
Med Lett Drugs Ther. 2009 Jun 29;51(1315):50-2 |  Show IntroductionHide Introduction

Vigabatrin (Sabril) for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Feb 22, 2010  (Issue 1332)
1000-3000 mg 10-20 mg/kg 40-60 mg/kg bid or Oxcarbazepine (Trileptal ...
The FDA has approved vigabatrin (vye gá ba trin; Sabril – Lundbeck) for oral use as add-on therapy for complex partial seizures in adults who are refractory to several antiepileptic drugs and as monotherapy for infantile spasms. Vigabatrin has been available in other countries for many years. Because of its potential for retinal toxicity, it will be available in the US only through a restricted distribution program called SHARE (Support, Help and Resources for Epilepsy). Prescribers and pharmacists distributing the drug must register, and patients must undergo visual field testing.
Med Lett Drugs Ther. 2010 Feb 22;52(1332):14-6 |  Show IntroductionHide Introduction

Transdermal Selegiline (Emsam)

   
The Medical Letter on Drugs and Therapeutics • May 22, 2006  (Issue 1235)
to raise serum concentrations of selegiline; concurrent use of carbamazepine or oxcarbazepine (Trileptal ...
The FDA recently approved the monoamine oxidase inhibitor (MAOI) selegiline in a transdermal (patch) formulation (Emsam - Bristol-Myers Squibb/Somerset) for treatment of major depressive disorder. Selegiline is also available in an oral formulation (Eldepryl, and others) for treatment of Parkinson's disease.
Med Lett Drugs Ther. 2006 May 22;48(1235):41-2 |  Show IntroductionHide Introduction